These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11995951)

  • 1. Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia.
    Bhattacharya SK; Bhattacharya D; Sairam K; Ghosal S
    Phytomedicine; 2002 Mar; 9(2):167-70. PubMed ID: 11995951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia.
    Bhattachary SK; Bhattacharya D; Muruganandam AV
    Indian J Exp Biol; 2000 Sep; 38(9):945-7. PubMed ID: 12561957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant activity of glycowithanolides from Withania somnifera.
    Bhattacharya SK; Satyan KS; Ghosal S
    Indian J Exp Biol; 1997 Mar; 35(3):236-9. PubMed ID: 9332168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Withania somnifera glycowithanolides on iron-induced hepatotoxicity in rats.
    Bhattacharya A; Ramanathan M; Ghosal S; Bhattacharya SK
    Phytother Res; 2000 Nov; 14(7):568-70. PubMed ID: 11054855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
    Naidu PS; Singh A; Kulkarni SK
    Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action.
    Naidu PS; Singh A; Kulkarni SK
    J Med Food; 2003; 6(2):107-14. PubMed ID: 12935321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
    Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of Morus alba leaves on haloperidol-induced orofacial dyskinesia and oxidative stress.
    Nade VS; Kawale LA; Yadav AV
    Pharm Biol; 2010 Jan; 48(1):17-22. PubMed ID: 20645751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals.
    Patil R; Hiray Y; Shinde S; Langade P
    Pharm Biol; 2012 Jun; 50(6):691-7. PubMed ID: 22136413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Lv MH; Zhou DF; Soares JC; Kosten TR; Yang FD; Zhang XY
    Behav Brain Res; 2016 Jan; 297():124-30. PubMed ID: 26455874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats.
    Rasool M; Varalakshmi P
    Fundam Clin Pharmacol; 2007 Apr; 21(2):157-64. PubMed ID: 17391288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs.
    Takeuchi H; Ishigooka J; Kobayashi K; Watanabe S; Miura S
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):679-91. PubMed ID: 9682280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucuna pruriens attenuates haloperidol-induced orofacial dyskinesia in rats.
    Pathan AA; Mohan M; Kasture AS; Kasture SB
    Nat Prod Res; 2011 Apr; 25(8):764-71. PubMed ID: 20635303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
    Burger ME; Fachinetto R; Zeni G; Rocha JB
    Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
    Naidu PS; Singh A; Kulkarni SK
    Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
    Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
    Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.